11:56 AM EST, 02/05/2025 (MT Newswires) -- Cosmos Health ( COSM ) filed a patent application for a treatment for multiple sclerosis.

This milestone highlights the partnership with Cloudpharm and the National Hellenic Research Foundation, supported by the pharma patent expert team at NLO Group, Cosmos Health ( COSM ) said Wednesday in a statement.

The patent is based on data from Cosmos Health's ( COSM ) artificial intelligence-powered Cloudscreen drug repurposing platform.

"Recent findings by Cosmos Health ( COSM ) have demonstrated the potential of a repurposed marketed drug for treating MS, with the inventors identifying a unique mechanism of action," according to the statement.

MS is an autoimmune disorder that affects the central nervous system.

Price: 0.7096, Change: +0.0096, Percent Change: +1.37